Davos 2027 Healthcare and Life Sciences Events: Companies, Investors and Leaders to Watch

Davos 2027 will bring healthcare, biopharma, medtech, digital health, longevity and life sciences into the wider policy and investment agenda. The most relevant activity will sit across official World Economic Forum programming, private houses, investor meetings, corporate receptions and specialist healthcare events.

The official WEF 2027 dates are 18–22 January 2027, with the Annual Meeting centred on the Davos Congress Centre. The detailed healthcare programme and most private Davos side events 2027 have not yet been fully published.

Davos 2027 healthcare calendar: what is confirmed

The World Economic Forum Annual Meeting 2027 is scheduled for 18–22 January 2027 in Davos-Klosters, according to the official Davos tourism listing, the Davos Congress Centre and the Municipality of Davos.

Healthcare and life sciences are expected to feature across themes including:

• Global health security and pandemic preparedness
• Health-system resilience and financing
• Biopharma, vaccines and access to medicines
• Artificial intelligence in healthcare
• Digital health infrastructure and data governance
• Women’s health, fertility and longevity
• Rare diseases and advanced therapies
• Climate-related health risks
• Healthcare workforce and care-economy reform

The official programme will determine which sessions are open, restricted or invitation-only. Until publication, references to specific panels, speakers or companies should be treated as indicative rather than confirmed.

The main healthcare platforms to monitor

World Economic Forum health programming

The WEF health track typically connects ministers, public-health institutions, pharmaceutical executives, investors and health-technology leaders. It is the most policy-oriented layer of the Davos healthcare ecosystem.

The relevant decision-makers are likely to include:

• Health ministers and senior government officials
• Heads of international health institutions
• CEOs and chairs of pharmaceutical companies
• Biotech and medtech founders
• Health-system operators
• Institutional investors and development-finance leaders
• Researchers and scientific advisers
• Technology executives working on AI and health data

The WEF meetings directory should be used for official programme updates. It remains separate from the wider commercial and private-event calendar in Davos.

Health-focused side programmes

Recent Davos programming has included platforms such as Health@Davos, which has addressed financing scale-ups, global health risk, AI, life sciences, fertility and longevity.

These formats are relevant to founders and investors because they combine policy discussion with direct business networking. They are also more accessible than the main Congress Centre for participants without formal WEF credentials.

Brain health and neuroscience

Brain health is becoming a distinct Davos theme. The Davos Alzheimer’s Collaborative Brain House and the European Brain Council’s Davos programme illustrate the type of platform likely to attract neuroscience companies, pharmaceutical groups, foundations, policymakers and impact investors.

Topics to watch include:

• Dementia prevention and diagnosis
• Brain capital and productivity
• Mental-health infrastructure
• Neurotechnology
• Ageing and cognitive decline
• Public-private research partnerships

Companies and sectors to watch

The 2027 attendee picture will remain fluid until companies publish their own Davos agendas. The strongest signals will come from corporate announcements, speaker confirmations, house schedules and side-event registration pages.

Sector Companies and institutions to monitor Strategic questions

Pharmaceuticals Global pharma companies, vaccine manufacturers and specialty-drug groups Access, pricing, supply security and innovation pipelines

Biotechnology Platform biotech, cell and gene therapy companies, synthetic biology firms Clinical validation, regulatory pathways and financing

Medtech Diagnostics, devices, robotics and surgical technology companies Adoption, reimbursement and healthcare productivity

Digital health Clinical software, remote care, health-data and AI companies Evidence, interoperability, safety and procurement

Longevity Ageing research, biomarkers and longevity therapeutics companies Clinical endpoints, capital formation and regulation

Health finance Healthcare venture funds, growth investors, family offices and development financiers Scale-up capital, exits and blended finance

Public health WHO-linked institutions, Gavi, foundations and government agencies Preparedness, immunisation and system resilience

Past participation offers useful signals but does not establish attendance in 2027. For example, Novartis publicly confirmed its participation in the 2026 Annual Meeting. Similar company announcements will become more informative as January approaches.

Investors to watch at Davos 2027

The Davos investors 2027 landscape will extend beyond traditional venture capital. Healthcare opportunities at Davos are usually evaluated across several capital pools:

• Specialist biotech and life sciences venture funds
• Growth-equity investors
• Family offices with healthcare allocations
• Sovereign wealth funds
• Pharmaceutical corporate-venture arms
• Strategic medtech investors
• Impact investors and philanthropic capital
• Development banks and public-sector financiers
• Institutional investors assessing healthcare infrastructure

Longevity is likely to remain a prominent investor theme. The Longevity Investors Lunch has operated as an application-based gathering for investors, scientists and companies focused on ageing research and therapeutics. Its 2027 date and format should be verified directly with the organiser.

For founders, the most valuable meetings will usually concern:

1. Clinical or technical validation
2. Regulatory and reimbursement strategy
3. Follow-on financing
4. Strategic partnerships
5. Manufacturing and commercial scale
6. Access to hospitals, insurers and public systems

Davos is rarely a substitute for a structured fundraising process. It is more useful as a concentration point for qualified introductions, strategic conversations and early-stage diligence.

Which leaders matter most?

A definitive Davos attendee list 2027 is unlikely to be available in full. The relevant leadership map should instead be built by function.

Corporate leaders

Track CEOs, chairs and chief strategy officers from:

• Large pharmaceutical companies
• Biotech scale-ups
• Medical-device manufacturers
• Diagnostics businesses
• Health insurers
• Hospital networks
• Digital-health platforms

Scientific leaders

Scientific credibility will be particularly important in biotechnology, longevity, neuroscience and AI-enabled diagnostics. Researchers with clinical, translational or regulatory influence may carry greater relevance than high-profile founders without validated programmes.

Policy leaders

Health ministers, regulators, public-health officials and multilateral leaders shape the conditions under which healthcare innovation reaches patients. Their presence can signal emerging priorities around procurement, data, resilience and access.

Capital allocators

Family-office principals, healthcare fund partners, sovereign investors and foundation leaders are important because they can support longer investment horizons than conventional venture capital.

The practical question behind “Who is attending Davos 2027?” is not simply which names are present. It is which people control capital, policy access, distribution, clinical validation or strategic partnerships.

Davos houses, receptions and networking events

The Davos houses 2027 programme will likely develop along the Promenade and around major hotels and meeting venues. Health-related houses may include:

• Pharmaceutical and biotechnology showcases
• National or regional health delegations
• AI and digital-health platforms
• Investor and family-office salons
• Longevity and ageing forums
• Brain-health initiatives
• Care-economy and health-finance roundtables

These venues are distinct from the official WEF Congress Centre. They may be hosted by companies, governments, foundations, media groups, investors or independent organisations.

For a useful overview of location planning, monitor the Davos Congress Centre event calendar and organiser websites rather than relying on unverified social-media listings.

How to attend healthcare events without a WEF badge

How to attend Davos without a WEF badge is one of the most practical questions for founders and investors. The answer is usually a combination of public registration, direct invitations and bilateral scheduling.

Practical routes

• Apply to relevant investor or sector-specific events
• Register through official event pages as soon as applications open
• Contact hosts with a precise reason for participation
• Secure introductions through investors, advisers or portfolio companies
• Arrange meetings at hotels and permitted venues
• Monitor corporate house announcements
• Use local event directories only as discovery tools, not final confirmation

A WEF badge is not required for every Davos networking event. However, access policies differ. Some events are open, some are application-only and others are restricted to invited guests.

Davos event registration should always be completed through the organiser’s verified website. Registration does not necessarily guarantee entry, and many private dinners require separate approval.

Planning accommodation, meetings and logistics

The most important Davos accommodation and venues decisions should be made early. January demand is concentrated, and meeting availability can become more limiting than hotel inventory.

A practical operating plan should include:

• Accommodation within walking distance of the Promenade or Congress Centre
• A primary meeting location and a weather-proof alternative
• Buffer time between appointments
• A clear daily route between houses and hotels
• Separate schedules for formal events and bilateral meetings
• A contact responsible for last-minute changes
• Registration records and invitation confirmations

India delegation and emerging-market participation

The India delegation Davos 2027 will be relevant to companies working across pharmaceuticals, digital health, affordable care, diagnostics, health manufacturing and technology infrastructure.

Potential areas of interest include:

• India’s pharmaceutical and vaccine manufacturing capacity
• Digital public infrastructure for healthcare
• Health-tech scale-ups
• AI-enabled diagnostics
• Global capability centres
• Hospital and insurance innovation
• Cross-border investment and research partnerships

The specific companies and officials attending should be confirmed through government, corporate and delegation announcements.

How to identify real deal opportunities

The most credible Davos deal opportunities usually emerge from conversations already supported by evidence. Founders should arrive with:

• A concise clinical or commercial progress summary
• Regulatory status
• Financing requirements
• Partnership criteria
• Key metrics and market assumptions
• A defined meeting objective
• A short list of strategic counterparties

Investors should distinguish between:

• Policy visibility and commercial traction
• Scientific promise and clinical validation
• Networking volume and qualified access
• Public announcements and executable commitments

Davos can accelerate trust and discovery. It does not eliminate diligence.

FAQ

What are the WEF 2027 dates for healthcare and life sciences events?

The World Economic Forum Annual Meeting is scheduled for 18–22 January 2027 in Davos-Klosters. The precise healthcare agenda and associated sessions will be published closer to the event.

Are Davos healthcare side events part of the World Economic Forum?

Not necessarily. Many World Economic Forum 2027 events take place through official channels, while private houses, receptions and investor meetings are independently organised. The Davos ecosystem should not be treated as a single event.

Can founders attend Davos healthcare events without a WEF badge?

Yes. Some Davos side events 2027 are open or application-based, while others are invitation-only. Access depends on the organiser, venue and participant profile.

When will the Davos attendee list 2027 be available?

There is unlikely to be one complete public list. Company announcements, official speakers, house programmes and verified event registrations will provide a more accurate picture over time.

Conclusion

Davos 2027 healthcare activity will span official policy sessions, corporate houses, investor meetings, specialist congresses and private networking. The strongest participants will prepare around specific counterparties, verified event access and measurable strategic objectives.

The Davos Collective provides independent intelligence on the networks, conversations and decision-makers shaping the Davos ecosystem, and is not affiliated with the World Economic Forum.